Literature DB >> 6317888

Isolation of transformation-defective, replication-nondefective early region 1B mutants of adenovirus 12.

Y Fukui, I Saito, K Shiroki, H Shimojo.   

Abstract

We isolated three adenovirus 12 early region 1B mutants (in205B, in205C, and dl205) by ligation of the cleaved DNA-protein complex and transfection of human embryo kidney cells with the ligation products. These mutants could replicate efficiently in human embryo kidney or KB cells but showed markedly reduced transforming capacities both in vitro and in vivo. In cells infected with the mutants, the early region 1B gene was transcribed efficiently. In cells infected with in205B, the products corresponding to the early region 1B-coded 19,000-molecular-weight polypeptide was detected by in vitro translation but not immunoprecipitated extract of labeled cells. In cells infected with in205C or dl205, the products corresponding to the same polypeptide were not detected by either in vitro translation or immunoprecipitation of labeled cell extracts. The results suggest that the 19,000-molecular-weight polypeptide encoded by early region 1B is required for cell transformation but not for viral propagation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6317888      PMCID: PMC255436     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  Studies on in vitro transformation by DNA and DNA fragments of human adenoviruses and simian virus 40.

Authors:  F L Graham; P J Abrahams; C Mulder; H L Heijneker; S O Warnaar; F A De Vries; W Fiers; A J Van Der Eb
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

3.  Transformation of a rat cell line by an adenovirus type 12 DNA fragment.

Authors:  S Yano; S Ojima; K Fujinaga; K Shiroki; H Shimojo
Journal:  Virology       Date:  1977-10-01       Impact factor: 3.616

4.  Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids.

Authors:  A J Berk; P A Sharp
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

5.  Establishment and characterization of rat cell lines transformed by restriction endonuclease fragments of adenovirus 12 DNA.

Authors:  K Shiroki; H Handa; H Shimojo; S Yano; S Ojima; K Fujinaga
Journal:  Virology       Date:  1977-10-15       Impact factor: 3.616

6.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

Authors:  F L Graham; J Smiley; W C Russell; R Nairn
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

7.  A new method for sequencing DNA.

Authors:  A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

8.  Incomplete transformation of rat cells by a small fragment of adenovirus 12 DNA.

Authors:  K Shiroki; H Shimojo; Y Sawada; Y Uemizu; K Fujinaga
Journal:  Virology       Date:  1979-05       Impact factor: 3.616

9.  Transformation with specific fragments of adenovirus DNAs. II. Analysis of the viral DNA sequences present in cells transformed with a 7% fragment of adenovirus 5 DNA.

Authors:  A J Van der Eb; A Houweling
Journal:  Gene       Date:  1977       Impact factor: 3.688

10.  Transformation with specific fragments of adenovirus DNAs. I. Isolation of specific fragments with transforming activity of adenovirus 2 and 5 DNA.

Authors:  A J Van der Eb; C Mulder; F L Graham; A Houweling
Journal:  Gene       Date:  1977       Impact factor: 3.688

View more
  25 in total

1.  Overexpression of the E1B 55-kilodalton (482R) protein of human adenovirus type 12 appears to permit efficient transformation of primary baby rat kidney cells in the absence of the E1B 19-kilodalton protein.

Authors:  S Zhang; S Mak; P E Branton
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

2.  Ability of p53 and the adenovirus E1b 58-kilodalton protein to form a complex is determined by p53.

Authors:  A W Braithwaite; J R Jenkins
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

3.  Specific disruption of intermediate filaments and the nuclear lamina by the 19-kDa product of the adenovirus E1B oncogene.

Authors:  E White; R Cipriani
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

4.  Structure of viral DNA in a rat cell line transformed by the cloned EcoRI-C fragment of adenovirus 12.

Authors:  Y Kawarabayasi; H Sugisaki
Journal:  Nucleic Acids Res       Date:  1985-09-25       Impact factor: 16.971

5.  Adenovirus type 12 E1B 19-kilodalton protein is not required for oncogenic transformation in rats.

Authors:  C Edbauer; C Lamberti; J Tong; J Williams
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

6.  Activation of the human beta interferon gene by the adenovirus type 12 E1B gene.

Authors:  K Shiroki; M Toth
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

7.  An insertion mutation in the adenovirus type 12 early region 1A 13S mRNA unique region.

Authors:  K Ohshima; K Shiroki
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

8.  Expression of adenovirus E1B mutant phenotypes is dependent on the host cell and on synthesis of E1A proteins.

Authors:  E White; B Stillman
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

9.  Expression of the E4 gene is required for establishment of soft-agar colony-forming rat cell lines transformed by the adenovirus 12 E1 gene.

Authors:  K Shiroki; S Hashimoto; I Saito; Y Fukui; Y Fukui; H Kato; H Shimojo
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

10.  The replicative capacities of large E1B-null group A and group C adenoviruses are independent of host cell p53 status.

Authors:  A S Turnell; R J Grand; P H Gallimore
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.